Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2004
04/27/2004US6727066 Complementary dna; hyperlipidemia; high throughput assay/screening; medical diagnosis
04/27/2004US6727065 Methods of use of semiconductor nanocrystal probes for treating a material
04/27/2004US6727062 Identification of target structures E.G. in vivo selection method for a phage library
04/27/2004US6727060 Diagnosing viral disease in humans; obtain sample, incubate with antibody, detect signal from sample
04/27/2004US6726938 Fagopyrum cymosum (Trev.) Meisn composition, method to prepare and analyze the same and uses thereof
04/27/2004US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
04/27/2004US6726883 Spotting pin
04/27/2004US6726882 To detect residual hydrocarbon contamination on a surface
04/27/2004US6726881 Measurement chip for surface plasmon resonance biosensor
04/27/2004US6726843 Inverse chromatography methods and apparatus for evaluation of interactions between modifying agents and receptors comprising natural or artificial mammalian tissue
04/27/2004US6726818 Biosensors with porous chromatographic membranes
04/27/2004US6726739 Method of treating metal analysis sample and device thereof
04/27/2004US6726671 Cell storage maintenance and monitoring system
04/27/2004US6726637 Breath collection apparatus
04/27/2004CA2295999C Nik proteins, nucleic acids and methods
04/27/2004CA2152166C Process for detecting fibrocystic desease or a cftr gene mutation
04/25/2004CA2444995A1 Machine for moving containers in front of control points
04/24/2004WO2004038042A1 A 4-dimensional method and equipment of detecting nucleic acid hybrid pair on the gene chip
04/24/2004CA2429101A1 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters
04/22/2004WO2004034208A2 System and method for identifying a food event, tracking the food product, and assessing risks and costs associated with intervention
04/22/2004WO2004034064A1 Apparatus and method for testing moisture susceptibility, rutting and fatigue of material
04/22/2004WO2004034063A2 Detecting apparatus
04/22/2004WO2004034062A2 Use of cap-1 for the therapy of asthma
04/22/2004WO2004034061A2 Method for determining the susceptibility of a subject to infection
04/22/2004WO2004034060A2 Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage
04/22/2004WO2004034059A1 Methods for detection of breast cancer
04/22/2004WO2004034058A1 A method for measuring antioxidant status
04/22/2004WO2004034056A2 Portable diagnostic device and method for determining temporal variations in concentrations
04/22/2004WO2004034055A2 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells
04/22/2004WO2004034054A2 Method for enhancing and prolonging the bioluminescence resonance energy transfer (bret) signal in a bret assay and a substrate solution for use in a bret assay
04/22/2004WO2004034053A2 Sensor strip having a capillary flow channel with a flow terminating interface
04/22/2004WO2004034052A1 High throughput assay system
04/22/2004WO2004034051A1 Portable carbon monoxide generation apparatus for testing co sensors, detectors and alarms
04/22/2004WO2004034050A1 Solid state sensor for carbon monoxide
04/22/2004WO2004034047A1 Column for analytical temperature rising elution fractionation (atref)
04/22/2004WO2004034033A2 Methods and systems for detecting mhc class i and class ii binding peptides
04/22/2004WO2004034031A2 A method for diagnosis and prognosis of multiple sclerosis
04/22/2004WO2004034025A2 Nano-chem-fet based biosensors
04/22/2004WO2004034022A2 Shape optimization to solve inverse problems and curve/model fitting problems
04/22/2004WO2004034020A2 Hydrodynamic micromanipulation of individual cells to patterned attachement sites
04/22/2004WO2004034018A2 Multihued labels
04/22/2004WO2004034013A2 Genotoxicity analysis
04/22/2004WO2004034012A2 Coded particles for multiplexed analysis of biological samples
04/22/2004WO2004033723A2 Neurodegenerative disease-associated gene
04/22/2004WO2004033720A2 Analytical chip for detection of 16s-rrna from clinically relevant bacteria and analytical method based thereon
04/22/2004WO2004033716A1 Examination method and examination diagnostic for periodontal disease
04/22/2004WO2004033714A1 Identification and modulation of intermediates of alcohol metabolism
04/22/2004WO2004033687A1 Method of screening remedy for renal failure
04/22/2004WO2004033686A1 Novel protein and dna thereof
04/22/2004WO2004033681A1 Substance having activity of promoting platelet aggregation
04/22/2004WO2004033677A2 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph
04/22/2004WO2004033675A1 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic
04/22/2004WO2004033667A2 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
04/22/2004WO2004033654A2 Automated method for high throughput screening of nematodes
04/22/2004WO2004033647A2 Assay methods for state-dependent calcium channel agonists/antagonists
04/22/2004WO2004033640A2 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter
04/22/2004WO2004033631A2 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
04/22/2004WO2004033626A2 Hyperglycosylated hcg (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease
04/22/2004WO2004033459A1 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
04/22/2004WO2004033101A1 Diagnostic devices
04/22/2004WO2004033062A2 Integrated sample cell and filter and system using same
04/22/2004WO2004033059A2 Methods and apparatus for optophoretic diagnosis of cells and particles
04/22/2004WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase
04/22/2004WO2004032867A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
04/22/2004WO2004032851A2 Screening and therapeutic methods relating to neurogenesis
04/22/2004WO2004032850A2 Uses of human zven antagonists
04/22/2004WO2004032842A2 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers
04/22/2004WO2004032841A2 System for production and screening of monoclonal antibodies
04/22/2004WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
04/22/2004WO2004032716A2 Compounds for modulation of cholesterol transport
04/22/2004WO2004032711A2 Diagnosis and monitoring of inflammation, ischemia and appendicitis
04/22/2004WO2004032708A2 Vasoregulating compounds and methods of their use
04/22/2004WO2004032702A2 Apparatus and method for hematologic analysis
04/22/2004WO2004032622A2 Production of peptides in plants as viral coat protein fusions
04/22/2004WO2004032609A2 Systems and methods for rapidly and accurately identifying live eggs within a stream of eggs
04/22/2004WO2004032599A2 Novel immunogenic proteins of leptospira
04/22/2004WO2004024935A3 Process for analyzing the tear fluid
04/22/2004WO2004023096A3 Continuous tracer generation apparatus
04/22/2004WO2004020983A3 Ultrafiltration device for drug binding studies
04/22/2004WO2004019177A3 Device and method for testing paving materials
04/22/2004WO2004019038A3 Method for the detection of antibodies and/or antigens in a test liquid, particularly for determining the blood type
04/22/2004WO2004018976A3 Thermal gas flowmeter comprising a gas quality indicator
04/22/2004WO2004018704A9 Point source biological agent detection system
04/22/2004WO2004018699A3 Extraction and concentration method
04/22/2004WO2004015413B1 The method and apparatus for determining the number of living cells in a test fluid
04/22/2004WO2004015395A3 Method for identifying mhc-presented peptide epitopes for t cells
04/22/2004WO2004013623A3 Amperometric chloramine sensor
04/22/2004WO2004005544A3 Marker genes for determining renal toxicity
04/22/2004WO2004003549A3 Automatic differentiation of a sample solution and a control solution
04/22/2004WO2004003538A3 Multi-electrode device for detecting an analyte
04/22/2004WO2004000313A3 Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
04/22/2004WO2003107007A3 Rapid test method for detecting at least one antigen, and the use of the same
04/22/2004WO2003103607A3 Viral envelope mediated fusion assay
04/22/2004WO2003101958A3 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
04/22/2004WO2003099312A8 Method for determining immune system affecting compounds
04/22/2004WO2003097879A3 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
04/22/2004WO2003093790A3 Sensors for biomolecular detection and cell classification
04/22/2004WO2003093499A3 Therapeutic use of selective pde10 inhibitors
04/22/2004WO2003083102A3 Cancer associated protein phosphatases and their uses
04/22/2004WO2003079921A8 Diagnosis marker